Clinical trial
Comparison of Analgesic and Sedative Effects of Esmketamine and Remifentanil Combined With Propofol Respectively in Septic Shock Patients With Invasive Mechanical Ventilation
NCT05551910 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Analgesic and Sedative Effects of Esmketamine and Remifentanil Combined With Propofol Respectively in Septic Shock Patients With Invasive Mechanical Ventilation
- Lead sponsor
- The First Hospital of Jilin University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2023
- Completion date
- March 1, 2025
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
patients with septic shock admitted to the icu on invasive mechanical ventilation